Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’

Ann Oncol 2017; 28: 3000–3008 (doi: 10.1093/annonc/mdx527)

from Cancer via ola Kala on Inoreader https://ift.tt/2FLv4MW
via IFTTT